[Individualized prognosis in non-small-cell carcinoma. A multivariate approach]

Area of Science:

• Oncology
• Biostatistics

Context:

• Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality.
• Accurate initial prognosis is crucial for effective patient management and treatment planning.
• Stage II NSCLC patients present a heterogeneous group with varying survival outcomes.

Purpose:

• To develop a multivariate discriminant analysis model for individualized prognosis in stage II NSCLC patients.
• To identify key prognostic factors influencing short-term survival (within one year) after surgery.
• To evaluate the accuracy and predictive values of the developed prognostic model.

Summary:

• A multivariate discriminant analysis was performed on 93 stage II NSCLC patients who underwent surgery.
• Key predictors of poor prognosis included large tumor size, prolonged symptoms, low serum albumin, elevated alkaline phosphatase, multiple affected lymph nodes (N1), pneumonectomy, and perioperative complications.
• The model achieved 87.1% correct patient classification, with high sensitivity and specificity for predicting one-year mortality.

Impact:

• Provides a validated system for individualized prognosis in stage II NSCLC.
• Enhances clinical decision-making by integrating multiple prognostic indicators.
• Potential to improve patient counseling and treatment stratification for NSCLC.